The Utility of Presepsin as a Biomarker in Hospital acquired Septicemia in PICUs and NICUS.
Moubarak, I., Elanany, M., Osman, A., Gabari, M., Mohammed, I. (2024). The Utility of Presepsin as a Biomarker in Hospital acquired Septicemia in PICUs and NICUS.. EKB Journal Management System, (), -. doi: 10.21608/aumj.2024.254893.1092
Islam Ahmed Moubarak; Mervat Elanany; Asmaa Osman; Magda Farghalli Gabari; Islam Mohammed. "The Utility of Presepsin as a Biomarker in Hospital acquired Septicemia in PICUs and NICUS.". EKB Journal Management System, , , 2024, -. doi: 10.21608/aumj.2024.254893.1092
Moubarak, I., Elanany, M., Osman, A., Gabari, M., Mohammed, I. (2024). 'The Utility of Presepsin as a Biomarker in Hospital acquired Septicemia in PICUs and NICUS.', EKB Journal Management System, (), pp. -. doi: 10.21608/aumj.2024.254893.1092
Moubarak, I., Elanany, M., Osman, A., Gabari, M., Mohammed, I. The Utility of Presepsin as a Biomarker in Hospital acquired Septicemia in PICUs and NICUS.. EKB Journal Management System, 2024; (): -. doi: 10.21608/aumj.2024.254893.1092

The Utility of Presepsin as a Biomarker in Hospital acquired Septicemia in PICUs and NICUS.

Aswan University Medical Journal
Articles in Press, Accepted Manuscript, Available Online from 12 February 2024  XML
Document Type: Original Article
DOI: 10.21608/aumj.2024.254893.1092
View on SCiNiTO View on SCiNiTO
Authors
Islam Ahmed Moubarak email 1; Mervat Elanany2; Asmaa Osman3; Magda Farghalli Gabari4; Islam Mohammed5
1clinical pathology, Faculty of medicine, Aswan university, Aswan, Egypt
2Department of clinical pathology, Faculty of medicine , Cairo University, Cairo, Egypt.
3Department of clinical pathology, Faculty of medicine, Assiut, Assiut University, Egypt.
4Pediatrics department, Aswan university hospital, Aswan, Egypt
5Department of clinical pathology, Faculty of medicine , Aswan, Aswan University, Egypt.
Abstract
Background: Pediatric sepsis is a major cause of morbidity and mortality in babies and children all over the world. Pediatric sepsis has become more common in the last 20 years, and an increasing number of these patients have co-morbid illnesses. Objectives: To assess the utilization of presepsin as a biomarker for early septicemia identification and its prognosis in order to direct antibiotic treatment. Patient and methods: In this case-control study, 20 patients with suspected hospital-acquired septicemia and 20 non-septic patients served as the control group in the pediatric critical care unit and the neonatal intensive care unit at Aswan University Hospital. Results: The mean presepsin levels in the sepsis group were significantly greater than in the control group, and they decreased steadily over time in accordance with treatment, reflecting the strong power of presepsin in sepsis predection. Conclusion: Presepsin is a promising biomarker for diagnosis of nosocomial sepsis predict its prognosis.
Keywords
Pediatric Sepsis; biomarkers; presepsin
Statistics
Article View: 21